Coloplast A/S (Germany) Analysis
CBHD Stock | 81.22 0.32 0.39% |
Coloplast AS is overvalued with Real Value of 71.19 and Hype Value of 81.22. The main objective of Coloplast A/S stock analysis is to determine its intrinsic value, which is an estimate of what Coloplast AS is worth, separate from its market price. There are two main types of Coloplast A/S's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Coloplast A/S's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Coloplast A/S's stock to identify patterns and trends that may indicate its future price movements.
The Coloplast A/S stock is traded in Germany on XETRA Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Coloplast A/S's ongoing operational relationships across important fundamental and technical indicators.
Coloplast |
Coloplast Stock Analysis Notes
The company had not issued any dividends in recent years. Coloplast A/S had 5:1 split on the 19th of December 2012.Coloplast A/S Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Coloplast A/S's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Coloplast AS or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Coloplast A/S generated a negative expected return over the last 90 days |
Coloplast Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 22.73 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast A/S's market, we take the total number of its shares issued and multiply it by Coloplast A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 19th of July, Coloplast A/S shows the Standard Deviation of 1.86, risk adjusted performance of (0.09), and Mean Deviation of 1.19. Coloplast A/S technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Coloplast A/S treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if Coloplast A/S is priced correctly, providing market reflects its regular price of 81.22 per share.Coloplast A/S Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of Coloplast A/S for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Coloplast A/S short-term fluctuations and highlight longer-term trends or cycles.
Coloplast A/S Outstanding Bonds
Coloplast A/S issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Coloplast A/S uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Coloplast bonds can be classified according to their maturity, which is the date when Coloplast AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Coloplast A/S Predictive Daily Indicators
Coloplast A/S intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Coloplast A/S stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Coloplast A/S Forecast Models
Coloplast A/S's time-series forecasting models are one of many Coloplast A/S's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Coloplast A/S's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Coloplast A/S to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Complementary Tools for Coloplast Stock analysis
When running Coloplast A/S's price analysis, check to measure Coloplast A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast A/S is operating at the current time. Most of Coloplast A/S's value examination focuses on studying past and present price action to predict the probability of Coloplast A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast A/S's price. Additionally, you may evaluate how the addition of Coloplast A/S to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |